The pharmaceutical sector’s share of tube production in Europe has remained steady at over 20 per cent for many years. Improved health services in eastern Europe and the emerging countries of South America and Asia coupled with rising per-capita income means demand will increase considerably. These opportunities should also benefit the tube.
Although increased numbers of plastic and laminate tubes are being used in the pharma sector today, aluminium tubes still account for the lion’s share because of their specific benefits: good sterilisability guarantees perfect standards of hygiene, and outstanding barrier properties ensure optimal protection of sensitive contents and ensure that important constituents cannot escape. This means preparations remain fully effective for long periods of time.
All tubes allow contents to be removed hygienically and applied accurately in the exact prescribed dosage. Special dispenser and application systems also help. Last but not least, sophisticated tamper-proof solutions and efficient protection against product counterfeiting make the tube an even more valuable form of packaging, particularly in the sensitive medical field.